Essex Woodlands Management, Inc. - Q2 2022 holdings

$242 Million is the total value of Essex Woodlands Management, Inc.'s 9 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
BVS  BIOVENTUS$82,500,000
-51.6%
12,096,7020.0%34.10%
-17.3%
MDXG  MIMEDX GROUP, INC.$81,252,000
-26.3%
23,415,5840.0%33.58%
+26.0%
EYPT  EYEPOINT PHARMACEUTICALS INC$32,983,000
-35.2%
4,190,9210.0%13.63%
+10.7%
TELA BuyTELA BIO, INC.$24,996,000
-35.2%
3,565,709
+7.5%
10.33%
+10.8%
VERO  VENUS CONCEPT, INC.$7,515,000
-67.8%
21,169,4570.0%3.11%
-45.0%
RVNC  REVANCE THERAPEUTICS INC$6,317,000
-29.1%
457,0850.0%2.61%
+21.2%
 SONENDO INC$3,427,000
-57.1%
1,992,5260.0%1.42%
-26.7%
MNOV  MEDICINOVA INC$2,798,000
-5.2%
1,105,9410.0%1.16%
+62.0%
CBIO  CATALYST BIOSCIENCES INC$140,000
+169.2%
78,6220.0%0.06%
+346.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MEDICINOVA INC42Q3 20236.5%
REVANCE THERAPEUTICS INC39Q3 202344.6%
AXOGEN INC26Q4 202143.3%
ENDOLOGIX INC24Q1 201922.5%
ABIOMED INC20Q1 201852.1%
CORIUM INTL INC20Q1 201923.5%
TELA BIO, INC.16Q3 202331.5%
VENUS CONCEPT, INC.16Q3 202321.3%
ACURA PHARMACEUTICALS INC15Q1 20191.4%
CATALYST BIOSCIENCES INC15Q1 20191.0%

View Essex Woodlands Management, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Essex Woodlands Management, Inc.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (241927000.0 != 241928000.0)

Export Essex Woodlands Management, Inc.'s holdings